|
|
 |
 | Medical News Releases > Faculty Experts at Washington University in St. Louis >

Chief of the Division of Bone Marrow Transplantation and Stem Cell Biology
Expertise: bone marrow transplantation, leukemia/lymphoma, stem cell transplantation, graft vs. host disease
Bio: DiPersio helped pioneer stem cell transplants and now focuses his research efforts on improving the success of bone marrow and stem cell transplants for the treatment of cancer and disorders of the blood. He is investigating the use of gene therapy to control graft versus host disease that is a main obstacle to sucessful bone marrow and stem cell transplantation. He is also studying the genetic events associated with relapse in acute myelogenouse leukemia as well as innovations in supportive care of leukemia and transplant patients.
Education:
-
Ph.D. in Microbiology at University of Rocheste
-
M.D. in Medicine at University of Rochester

| News Stories & Tip Sheets: |
Showing 3 Stories.
|
 |
Viewing cancer at the molecular level
 Innovative molecular imaging center gets five-year, $10 million renewal grant

Nov. 8,
2007 -- An innovative cancer imaging center at the School of Medicine has received a five-year, $10 million grant from the National Cancer Institute (NCI). The grant will fund a second cycle of research at the Washington University Molecular Imaging Center, where scientists from many different specialties collaborate on advanced imaging projects.

|
New director
 Westervelt named director of bone marrow transplantation and leukemia

Aug. 23,
2006 -- Peter Westervelt, M.D., Ph.D., has been named director of the bone marrow transplantation and leukemia section of the Division of Oncology at the School of Medicine. Westervelt, associate professor of medicine, succeeds John F. DiPersio, M.D., Ph.D., professor of medicine, in the position.

|
New law to benefit cancer patients
 Gov. Blunt signs cancer legislation at Siteman Cancer Center

July 10,
2006 --
 |
| Gov. Matt Blunt with patient Rick Allenbrand, after Blunt signed a bill which requires health insurers to cover phase II clinical trials for cancer |
Download
|
For the past 12 years, WUSM physician John DiPersio and his colleagues at the Siteman Cancer Center have traveled en masse to Jefferson City in an effort to lobby the Missouri legislature about expanding medical coverage for cancer patients. After more than a decade, DiPersio says, "I'm delighted to say we've finally succeeded."

|
Showing 3 Stories.
|
 |
Affiliated with Barnes-Jewish Hospital and St. Louis Children's Hospital, members of BJC HealthCare.
Please contact us and let us know how we can assist you.
Technical problems with this Web site? Email questions or comments.
Please review the WUSTL News & Information copyright/privacy policy.
|  |
|
|  |  |
|